myirislogo
25 January, 2015 17:43 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 327.40 0.92
Tata Power 88.40 6.38
Hindalco In 144.90 0.91
Tata Stl 401.10 0.46
Sslt 204.90 1.91
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Strides Arcolab Limited
Strides Arcolab Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532531NSE:STARBloomberg:STR@INReuters:STAR.BO
Market Lot: 1Face Value: 10ISIN Demat: INE939A01011
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
20-JAN-15 Strides Arcolab, a pharmaceutical company manufacturing IP-led niche products, today announced that it has entered into a licensing agreement with Gilead Sciences under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. 16-DEC-14 Strides Arcolab, a pharmaceutical company manufacturing IP-led niche prod...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Strides Arcolab gets US FDA nod for Calcitriol Softgel Capsules  -IRIS 16-Dec-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Sep-2014(9)31-Dec-2013(12)31-Dec-2012 (12)
Net sales 6316.597515.976132.89
Other Income880.1014390.601189.08
Total Income7196.6921906.577321.96
Cost of goods sold5801.346901.046163.01
OPBDIT1395.3515005.531158.96
PAT3170.0135611.86559.86
Gross Block---
Equity capital595.66595.66588.04
EPS (Rs.)--9.55
DPS (Rs.)---
BV (Rs.)---
P/E range (x)--38.98 - 128.26
Debt / Equity (x)---
Operating margin (% of OI)19.468.515.8
Net margin (% of OI)44.0162.6 7.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
No 201, Devavrata
Sector 17
Vashi
Navi Mumbai
Maharashtra-400 705
PHONE
(022) 2789 3199/ 5247
FAX
(022) 2789 2924/ 42
 
Board of Directors
Board Meetings
Date Purpose
02-FEB-15 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer